Drug Database
Back to search

United States· US:50090-7604_1f95ff46-b4bf-42d3-b39b-b7221c7e07da

Colesevelam hydrochloride

A colesevelam product containing colesevelam hydrochloride, registered in United States by A-S Medication Solutions. The same ATC class is registered in 14 of our 19 countries.

ATC C10AC04US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedColesevelam hydrochlorideATCC10AC04REGISTER NO.US:50090-7604_1f95ff4…PACKS LISTED2CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about colesevelam hydrochlorideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Colesevelam is registered in 14 of 19 countries.

Countries holding a registration under ATC C10AC04 (colesevelam), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 8 of them publish a price we can compare per daily dose
Search colesevelam products by name

Colesevelam · ATC C10AC04

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of colesevelam costs, country by country.

Normalised to the WHO defined daily dose (3.75 g), the median price runs from $1.57 in United States to $5.96 in Spain — a ×3.8 gap.

  • United States: $1.57 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail
Open the full comparison — free accountDrug prices for market access

Colesevelam · price per daily dose (3.75 g)

USD · FX 28 Sept 2026

  • ES Spain$5.96
  • US United States$1.57 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
COLESEVELAM HYDROCHLORIDE
Manufacturer
A-S Medication Solutions
Country
United States (US)
ATC code
C10AC04
ATC class
Colesevelam
Defined daily dose
3.75 g, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    5009076040
    90 TABLET in 1 BOTTLE (50090-7604-0)
  • ndc11
    50090-7604-0

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

63 interactions on record for colesevelam.

Graded by severity as the source publishes them — 5 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check colesevelam against other medicinesHow interaction checks work

Colesevelam · interactions on record

63 records

  • 5 severe
  • 58 moderate

Most severe, free to view

  • BexaroteneL01XF03severe
  • BexarotenL01XX25severe
  • Mycophenolic acidL04AA06severe
  • TeriflunomidL04AA31severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Colesevelam in 7 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All colesevelam products

Authorised across Europe · EMA

The same active substance is authorised in 5 EEA countries. Names it is sold under:

  • Germany · Colesevelamhydrochlorid Ascend
  • United Kingdom (Northern Ireland) · Colesevelam Hydrochloride Consilient Health, Colesevelam Hydrochloride Dr. Reddy's Laboratories (Uk)
  • Iceland · Cholestagel
  • Liechtenstein · Cholestagel
  • Norway · Cholestagel

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ceed8a5e-31c6-425b-87f0-0e3847fe1882
GET /v1/drugs/ceed8a5e-31c6-425b-87f0-0e3847fe1882?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "625",
  "substance": "COLESEVELAM HYDROCHLORIDE",
  "productndc": "50090-7604",
  "dosage_form": "TABLET",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA209946",
  "marketing_category": "ANDA"
}
API referenceMCP serverPlans

See everything about colesevelam.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console